Log in
Enquire now
‌

US Patent 10472327 6-aminoisoquinoline compounds

Patent 10472327 was granted and assigned to Aerie Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Aerie Pharmaceuticals
Aerie Pharmaceuticals
Date Filed
December 29, 2017
Date of Patent
November 12, 2019
Patent Application Number
15858981
Patent Citations
‌
US Patent 10112920 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
‌
US Patent 10174017 Dual mechanism inhibitors for the treatment of disease
Patent Citations Received
‌
US Patent 12018012 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
‌
US Patent 11618748 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 11707460 Ophthalmic compositions
0
‌
US Patent 11891376 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
‌
US Patent 11590123 Ophthalmic compositions
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10472327
Patent Primary Examiner
‌
Zinna Northington Davis

Find more entities like US Patent 10472327 6-aminoisoquinoline compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.